Click on a different letter in the list above for terms beginning with that letter.
Pharmacy medicines. This is a category of medicine which does not require a prescription but which has to be sold under the supervision of a pharmacist. "P" appears on the label.
Primary and community care.
Picture Archiving and Communications Systems.
Picture Archiving and Communications Systems National Evaluation Team. Provides independent technical evaluation of PACS.
Proprietary Association of Great Britain. This association represents represents manufacturers mainly producing OTC/P medicines.
A pharmaceutical product therapeutically equivalent to an existing licensed UK product and licensed in the UK in accordance with the rules of the parallel import scheme.
Primary care trust.
Patient Group Directions. PGDs are written instructions for the supply or administration of medicines to groups of patients who may not be individually identified before presentation for treatment.
Pharmacovigilance Expert Advisory Group.
Independent assessor(s) appointed by the Licensing Authority to hear an appeal against a proposed licensing action.
Positron emission tomography.
Positron emission tomography (PET) and computerized tomography (CT).
A compendium of standards for pharmaceutical or chemical substances.
A technical term used for identifying and responding to risk/benefit issues emerging for authorised medicines as used in clinical practice, and including the effective dissemination of such information to optimise the safe and effective use of medicines.
A commonly used abbreviation for the European Pharmacopoeia.
Pharmaceutical Inspection Convention. An international organisation which mutually recognises inspection reports on manufacturers (excludes EC members).
Pharmaceutical Inspection Co-operation Scheme. The scheme's goal is to improve cooperation between regulatory authorities and the pharmaceutical industry in the field of Good Manufacturing Practice.
Patient Information Expert Advisory Group.
Patient Information Leaflet. A leaflet authorised by the MHRA supplied by the manufacturer of a licensed medicine to the patient.
Patient Information Quality. Part of VRMM Division dealing with labelling and leaflets for medicines. [Formerly: Patient Information Unit].
Product Licence. See: MA [Marketing Authorisation].
PL(PI) Product Licence (Parallel Import) See also Parallel Import.
Product Licence of Right. This is a licence granted to medicines already on the Market when the 1968 Medicines Act came into force. See also Committee on Review of Medicines.
Product Licence User System. See: Sentinel.
Post-Marketing Surveillance. This is adverse reaction monitoring for medicines already in the UK market.
Prescription only medicines i.e. medicines available only on prescription from a doctor.
POM TO P
The means by which a Prescription Only Medicine can become a Pharmacy Medicine [i.e. available only from a pharmacist]. It is also known as "de-pomming."
Patient Pack Initiative.
Parliamentary Question - a question asked by an MP in the House of Commons or from a member of the House of Lords. This may be an oral question or one put down for a written answer.
Proportioned Reporting Ratios.
Periodic Safety Update reports. Once a medical product is registered in the EU, Periodic Safety Update Reports (PSUR) must be submitted. These provide an update of the worldwide safety experience of a medicinal product to Competent Authorities at defined time points post-authorisation.